Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1238 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

CHMP recommends against UCB fibromyalgia drug

Xyrem is an oral solution that contains the active substance sodium oxybate (500mg/ml). Xyrem is indicated for the treatment of narcolepsy with cataplexy in adults. UCB said that

China Botanic Q1 net sales up 32.1%

China Botanic is a company engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines (TCM), in the People’s Republic of